Pegaspargase biosimilar (Amega Biotech)

培门冬酶生物类似药(Amega Biotech)

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegaspargase biosimilar (Amega Biotech)
Drug Alias Name培门冬酶生物仿制药(Amega Biotech)PEG-asparaginase biosimilarpegaspargase follow-on biologic
ClassificationBiologics > Protein drugs > EnzymeBiologics > Biosimilar
Mechanisms of ActionAsparagine stimulants
TargetsAsparagine
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAmega Biotech
China Registration ClassN/A

Develop Information

Active CompaniesAmega Biotech
Inactive CompaniesN/A
Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeL01XX24
Related LinksN/A